Literature DB >> 10684311

Herpes simplex virus ICP27 induces cytoplasmic accumulation of unspliced polyadenylated alpha-globin pre-mRNA in infected HeLa cells.

P Cheung1, K S Ellison, R Verity, J R Smiley.   

Abstract

Transcripts of most intron-bearing cellular genes must be processed by the splicing machinery in order to efficiently accumulate and gain access to the cytoplasm. However, we found that herpes simplex virus induces cytoplasmic accumulation of both spliced and unspliced polyadenylated alpha-globin RNAs in infected HeLa cells. Accumulation of the unspliced RNA required the immediate-early protein ICP27, and ICP27 was sufficient (in combination with ICP4) to produce this effect in a transient-transfection assay. However, expression of ICP27 did not markedly alter the levels of fully spliced alpha-globin transcripts in infected cells. These data demonstrate that the previously documented effects of ICP27 on the cellular splicing apparatus do not greatly inhibit splicing of alpha-globin RNA and argue that ICP27 induces a splicing-independent pathway for alpha-globin RNA accumulation and nuclear export.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10684311      PMCID: PMC111785          DOI: 10.1128/jvi.74.6.2913-2919.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Intronless mRNA transport elements may affect multiple steps of pre-mRNA processing.

Authors:  Y Huang; K M Wimler; G G Carmichael
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

2.  Splicing and the formation of stable RNA.

Authors:  D H Hamer; P Leder
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

Review 3.  The HIV-1 Rev protein.

Authors:  V W Pollard; M H Malim
Journal:  Annu Rev Microbiol       Date:  1998       Impact factor: 15.500

Review 4.  The organization and expression of histone gene families.

Authors:  C C Hentschel; M L Birnstiel
Journal:  Cell       Date:  1981-08       Impact factor: 41.582

5.  A herpes simplex virus type 1 function continuously required for early and late virus RNA synthesis.

Authors:  R J Watson; J B Clements
Journal:  Nature       Date:  1980-05-29       Impact factor: 49.962

6.  Gene-specific transactivation by herpes simplex virus type 1 alpha protein ICP27.

Authors:  S A Rice; D M Knipe
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

7.  Herpes simplex virus 1 mutant deleted in the alpha 22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in mice.

Authors:  A E Sears; I W Halliburton; B Meignier; S Silver; B Roizman
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

8.  Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4.

Authors:  N A DeLuca; A M McCarthy; P A Schaffer
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

9.  Herpes simplex virus type 1 ICP27 is an essential regulatory protein.

Authors:  W R Sacks; C C Greene; D P Aschman; P A Schaffer
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

10.  Detailed analysis of the portion of the herpes simplex virus type 1 genome encoding glycoprotein C.

Authors:  R J Frink; R Eisenberg; G Cohen; E K Wagner
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

View more
  20 in total

1.  Processing of alpha-globin and ICP0 mRNA in cells infected with herpes simplex virus type 1 ICP27 mutants.

Authors:  K S Ellison; S A Rice; R Verity; J R Smiley
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Epstein-Barr virus SM protein interacts with mRNA in vivo and mediates a gene-specific increase in cytoplasmic mRNA.

Authors:  V Ruvolo; A K Gupta; S Swaminathan
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  The Epstein-Barr virus SM protein induces STAT1 and interferon-stimulated gene expression.

Authors:  Vivian Ruvolo; Lorena Navarro; Clare E Sample; Michael David; Seung Sung; Sankar Swaminathan
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

4.  The herpes simplex virus 1 UL41 gene-dependent destabilization of cellular RNAs is selective and may be sequence-specific.

Authors:  Audrey Esclatine; Brunella Taddeo; Linton Evans; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

5.  Control of VP16 translation by the herpes simplex virus type 1 immediate-early protein ICP27.

Authors:  Kimberly S Ellison; Robert A Maranchuk; Kelly L Mottet; James R Smiley
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  Mapping of functional regions in the amino-terminal portion of the herpes simplex virus ICP27 regulatory protein: importance of the leucine-rich nuclear export signal and RGG Box RNA-binding domain.

Authors:  Joy Lengyel; Chandra Guy; Vivian Leong; Sarah Borge; Stephen A Rice
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 7.  Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine.

Authors:  Lisa E Pomeranz; Ashley E Reynolds; Christoph J Hengartner
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

8.  Herpes simplex virus ICP27 increases translation of a subset of viral late mRNAs.

Authors:  Errin C Fontaine-Rodriguez; David M Knipe
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

9.  Transactivation of a viral target gene by herpes simplex virus ICP27 is posttranscriptional and does not require the endogenous promoter or polyadenylation site.

Authors:  Keith D Perkins; Jennifer Gregonis; Sarah Borge; Stephen A Rice
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  The stress-inducible immediate-early responsive gene IEX-1 is activated in cells infected with herpes simplex virus 1, but several viral mechanisms, including 3' degradation of its RNA, preclude expression of the gene.

Authors:  Brunella Taddeo; Audrey Esclatine; Weiran Zhang; Bernard Roizman
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.